These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma. Islam F; Gopalan V; Lam AK Methods Mol Biol; 2020; 2129():259-268. PubMed ID: 32056183 [TBL] [Abstract][Full Text] [Related]
5. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma. Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952 [TBL] [Abstract][Full Text] [Related]
7. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients. Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111 [TBL] [Abstract][Full Text] [Related]
8. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma. Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153 [TBL] [Abstract][Full Text] [Related]
9. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma. Islam F; Gopalan V; Lam AK Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178 [TBL] [Abstract][Full Text] [Related]
10. Roles of MicroRNAs in Esophageal Squamous Cell Carcinoma Pathogenesis. Islam F; Gopalan V; Lam AK Methods Mol Biol; 2020; 2129():241-257. PubMed ID: 32056182 [TBL] [Abstract][Full Text] [Related]
11. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related]
12. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related]
13. Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma. Li Y; Zhang Q; Peng B; Shao Q; Qian W; Zhang JY Tumour Biol; 2014 Nov; 35(11):10871-7. PubMed ID: 25085586 [TBL] [Abstract][Full Text] [Related]
14. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma. Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359 [TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma. Ren P; Ye H; Dai L; Liu M; Liu X; Chai Y; Shao Q; Li Y; Lei N; Peng B; Yao W; Zhang J Oncol Rep; 2013 Nov; 30(5):2297-303. PubMed ID: 24009050 [TBL] [Abstract][Full Text] [Related]
18. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions. Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis. Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518 [TBL] [Abstract][Full Text] [Related]
20. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]